FindTrial
Sign In

effect turpentine of Pistacia Atlantica on asthema

Evaluation of the effects turpentine of Pistacia Atlantica on clinical symptoms and severity of asthma in patients with mild to moderate allergic asthma:A randomized clinical

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110720007065N3
Enrollment
150
Registered
2022-12-13
Start date
2022-08-23
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma. Asthma

Interventions

Intervention 1: Intervention group: receives standard asthma treatment( Beta agonist drugs and corticosteroids) and capsules containing turpentine extract(Sepidaj company) 500 mg every 12 hours for o

Sponsors

Yasouj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age range from 18 to 65 years, mild and moderate persistent allergic asthma according to GINA criteria body mass index (BMI) up to 27 kg/m2

Exclusion criteria

Exclusion criteria: smoking pregnancy breastfeeding diabetes autoimmune disease malignancy other lung diseases (COPD, tuberculosis) severe asthma

Design outcomes

Primary

MeasureTime frame
Asthma. Timepoint: The time of the intervention and one month after the intervention. Method of measurement: Physical examinations, history , questionnaire.;Eozinofili. Timepoint: The time of the intervention and one month after the intervention. Method of measurement: test labratory.;Imunoglobulina E (Ig E). Timepoint: The time of the intervention and one month after the intervention. Method of measurement: test labratory.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Fatemeh Hekmatzadeh

Yasouj University of Medical Sciences

sf.hekmatzadeh@yahoo.com+98 74 3323 0290

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026